Global Natural Killer (NK) Cell Therapeutics Market: Investment & Growth Opportunity Analysis, 2023-2030
- Report ID: 64222
- Date: May, 2023
- Pages: 120
- Category: Healthcare & Pharmaceuticals
Global Natural Killer (NK) Cell Therapeutics Market: Investment & Growth Opportunity Analysis, 2023-2030
Market Introduction
The Global Natural Killer (NK) Cell Therapeutics market is estimated to grow at a robust CAGR of 51.8% during the forecast period of 2023-2030. The market growth is attributed to the increasing interest of the pharmaceutical industry players in cellular immunotherapy. NK cell therapeutics is anticipated to witness robust growth during the forecast period owing to its ability to fulfil unmet medical needs, overcome limitations associated with existing immunotherapies, and address complex and challenging targets.
The recent increase in the number of approvals received for cancer immunotherapies is considered to have added value to the NK cell therapeutic market. Moreover, market players are making efforts for the development of novel NK cell therapies which further gives a boost to the growth of the market. For instance, Under the agreement, Gilead would receive an exclusive, worldwide license from Dragonfly for the 5T4-targeting investigational immunotherapy program, DF7001. DF7001 is a TriNKET designed to activate and direct NK and cytotoxic T cell killing against cancer cells. The target of DF7001 is 5T4, a protein expressed on cancer cells and stromal cells that support tumor growth associated with poor prognosis in several cancers, including non-small cell lung cancer (NSCLC), pancreatic cancer, breast cancer, and head and neck squamous cell carcinomas (HNSCC).
Market Segmentation
The global NK cell therapeutics market has been analyzed on the basis of application, end user, and region. On the basis of application, the market is segmented into Cancer, Gastrointestinal Diseases, Immunoproliferative Disorders, and Others. Cancer segment is expected to dominate the global market. Based on end user, the market is divided into hospitals and research centers & institutes. Geographically, the market is segmented into North America, Latin America, Western Europe, Eastern Europe, Asia Pacific and Middle East & Africa. North America is dominating the global NK cell therapeutics market.
Market Structure and Competitive Landscape
Some of the prominent players that contribute significantly to the growth of the global NK cell therapeutics market include Nkarta, Inc, Bristol-Myers Squibb Company, Takeda Pharmaceutical Company Limited, Affimed GmbH, Zelluna Immunotherapy, Nektar Therapeutics, XNK Therapeutics AB, ONK Therapeutics, Catarman Bio, MiNK Therapeutics, Celularity Inc., Artiva Biotherapeutics and others. These players adopt various strategies to reinforce their market share and gain a competitive edge over other competitors in the market. Partnerships and collaborations, research & development, and product launches are some of the strategies followed by industry players. Some of the key developments in the global NK cell therapeutics market include,
• In August 2022, Zelluna Immunotherapy announced an investment from Takeda Ventures, Inc. (TVI), the strategic investing arm of Takeda. TVI investment joins Zelluna’s latest financing round. The funds will enable the advancement of a lead TCR-NK product through manufacturing to Clinical Trial Application (CTA) / Investigational New Drug Application (IND) readiness and, continue the advancement of Zelluna’s platform with additional programs reaching the preclinical stage.
• In January 2022, Takeda announced to acquire Adaptate Biotherapeutics to Develop Novel Gamma Delta (γδ) T Cell Engager Therapies Targeting Solid Tumors. Through the acquisition, Takeda would obtain Adaptate’s antibody-based γδ T cell engager platform, including pre-clinical candidate and discovery pipeline programs.
Global NK Cell Therapeutics Market Analysis and Forecast 2023-2030
Table of Contents
1. Market Introduction
1.1. Scope of Study
1.2. Problem Statement
1.3. Market Segmentation
2. Assumptions and Acronyms
3. Executive Summary
3.1. Global Market in 2023
3.2. Analyst Insights & Recommendations
3.3. Growth Opportunities and Key Strategies
3.4. Supply-side and Demand-side Trends
4. Research Methodology
5. Analysis of COVID-19 Impact and Road Ahead
6. Market Indicators and Background
6.1. Macro-Economic Factors
6.2. Forecasting Factors
Robust assessment of various factors including industrial performance, healthcare expenditures, industry players’ expenditures, economic conditions, among others
6.3. Supply Chain & Value Chain Analysis
6.4. Industry SWOT Analysis
6.5. PESTLE Analysis
6.6. Porter’s Five Forces Analysis
7. Government Laws and Industry Regulations
8. Global and Regional Market Dynamics
8.1. Drivers
8.2. Restraints
8.3. Trends
8.4. Opportunities
9. Global NK Cell Therapeutics Market: Key Investment Analysis
9.1. By Key Industry Players
9.2. By End User
9.3. By Therapeutic Application
9.4. By Region
9.5. M&A Activities
Robust assessment of major investments made by various industry players along with key therapeutic application areas, therapy type, and key region
10. Parent Market Overview: Global Healthcare & Life Sciences Market
11. Market Developments: Cell & Gene Therapy Products
11.1. By Region
11.1.1. North America
11.1.2. Latin America
11.1.3. Western Europe
11.1.4. Eastern Europe
11.1.5. Asia Pacific
11.1.6. Middle East & Africa
12. Clinical Trials Analysis
Exhaustive list of all the clinical trials sponsored by various industry players based on various cell types will be provided. Moreover, it would also categorize the trials into IND submissions, Phase I, Phase II etc.
13. Segmental Analysis
13.1. Global NK Cell Therapeutics Market by Application
13.1.1. Segment Overview
13.1.1.1. Cancer
13.1.1.2. Gastrointestinal Diseases
13.1.1.3. Immunoproliferative Disorders
13.1.1.4. Others
13.2. Global NK Cell Therapeutics Market by End User
13.2.1. Segment Overview
13.2.1.1. Hospitals
13.2.1.2. Research Centers and Institutes
13.2.1.3. Others
13.3. Global NK Cell Therapeutics Market by Region
13.3.1. North America
13.3.2. Latin America
13.3.3. Western Europe
13.3.4. Eastern Europe
13.3.5. Asia Pacific
13.3.6. Middle East & Africa
14. Regional Analysis
14.1. North America NK Cell Therapeutics Market Analysis and Forecast 2023-2030
14.1.1. Regional Market Overview and Key Takeaways
14.1.2. North America NK Cell Therapeutics Market by Application
14.1.3. North America NK Cell Therapeutics Market by End User
14.1.4. North America NK Cell Therapeutics Market by Country
14.1.4.1. US
14.1.4.2. Canada
14.2. Latin America NK Cell Therapeutics Market Analysis and Forecast 2023-2030
14.2.1. Regional Market Overview and Key Takeaways
14.2.2. Latin America NK Cell Therapeutics Market by Application
14.2.3. Latin America NK Cell Therapeutics Market by End User
14.2.4. Latin America NK Cell Therapeutics Market by Country
14.2.4.1. Brazil
14.2.4.2. Mexico
14.2.4.3. Rest of Latin America
14.3. Western Europe NK Cell Therapeutics Market Analysis and Forecast 2023-2030
14.3.1. Regional Market Overview and Key Takeaways
14.3.2. Western Europe NK Cell Therapeutics Market by Application
14.3.3. Western Europe NK Cell Therapeutics Market by End User
14.3.4. Western Europe NK Cell Therapeutics Market by Country
14.3.4.1. Germany
14.3.4.2. UK
14.3.4.3. France
14.3.4.4. Spain
14.3.4.5. Italy
14.3.4.6. Benelux
14.3.4.7. Nordic
14.3.4.8. Rest of Western Europe
14.4. Eastern Europe NK Cell Therapeutics Market Analysis and Forecast 2023-2030
14.4.1. Regional Market Overview and Key Takeaways
14.4.2. Eastern Europe NK Cell Therapeutics Market by Application
14.4.3. Eastern Europe NK Cell Therapeutics Market by End User
14.4.4. Eastern Europe NK Cell Therapeutics Market by Country
14.4.4.1. Russia
14.4.4.2. Poland
14.4.4.3. Rest of Eastern Europe
14.5. Asia Pacific NK Cell Therapeutics Market Analysis and Forecast 2023-2030
14.5.1. Regional Market Overview and Key Takeaways
14.5.2. Asia Pacific NK Cell Therapeutics Market by Application
14.5.3. Asia Pacific NK Cell Therapeutics Market by End User
14.5.4. Asia Pacific NK Cell Therapeutics Market by Country
14.5.4.1. China
14.5.4.2. Japan
14.5.4.3. India
14.5.4.4. South Korea
14.5.4.5. Australia
14.5.4.6. ASEAN
14.5.4.7. Rest of Asia-Pacific
14.6. Middle East & Africa NK Cell Therapeutics Market Analysis and Forecast 2023-2030
14.6.1. Regional Market Overview and Key Takeaways
14.6.2. Middle East & Africa NK Cell Therapeutics Market by Application
14.6.3. Middle East & Africa NK Cell Therapeutics Market by End User
14.6.4. Middle East & Africa NK Cell Therapeutics Market by Country
14.6.4.1. GCC
14.6.4.2. South Africa
14.6.4.3. Turkey
14.6.4.4. Rest of the Middle East & Africa
15. Competitive Landscape
15.1. Competition Dashboard
15.1.1. Global and Regional Market Share Analysis
15.1.2. Market Structure
15.2. Competitive Benchmarking
15.3. Key Strategy Analysis
15.4. Company Profiles
15.4.1. Affimed GmbH
15.4.1.1. Company Overview
15.4.1.2. Application/Service Offerings
15.4.1.3. Key Financials
15.4.1.4. Recent Developments
15.4.2. Bristol-Myers Squibb Company
15.4.2.1. Company Overview
15.4.2.2. Application/Service Offerings
15.4.2.3. Financials
15.4.2.4. Recent Developments
15.4.3. Nkarta Inc.
15.4.3.1. Company Overview
15.4.3.2. Application/Service Offerings
15.4.3.3. Financials
15.4.3.4. Recent Developments
15.4.4. Zelluna Immunotherapy AS
15.4.4.1. Company Overview
15.4.4.2. Application/Service Offerings
15.4.4.3. Financials
15.4.4.4. Recent Developments
15.4.5. XNK Therapeutics AB
15.4.5.1. Company Overview
15.4.5.2. Application/Service Offerings
15.4.5.3. Financials
15.4.5.4. Recent Developments
15.4.6. ONK Therapeutics
15.4.6.1. Company Overview
15.4.6.2. Application/Service Offerings
15.4.6.3. Financials
15.4.6.4. Recent Developments
15.4.7. Catamaran Bio
15.4.7.1. Company Overview
15.4.7.2. Application/Service Offerings
15.4.7.3. Financials
15.4.7.4. Recent Developments
15.4.8. MiNK Therapeutics
15.4.8.1. Company Overview
15.4.8.2. Application/Service Offerings
15.4.8.3. Financials
15.4.8.4. Recent Developments
15.4.9. Takeda Pharmaceutical Company Limited
15.4.9.1. Company Overview
15.4.9.2. Application/Service Offerings
15.4.9.3. Financials
15.4.9.4. Recent Developments
15.4.10. Celularity Inc.
15.4.10.1. Company Overview
15.4.10.2. Application/Service Offerings
15.4.10.3. Financials
15.4.10.4. Recent Developments
15.4.11. Artiva Biotherapeutics
15.4.11.1. Company Overview
15.4.11.2. Application/Service Offerings
15.4.11.3. Financials
15.4.11.4. Recent Developments
A comprehensive list of NK cell therapeutics providers will be provided along with geographical reach, employee count, revenue, product capacities, and their capabilities
16. Disclaimer
List of Tables
Global Natural Killer (NK) Cell Therapeutics Market
List of Figures
Figure 01: Global Natural Killer (NK) Cell Therapeutics Market Volume (‘000 tones), 2019-2022
Figure 02: Global Natural Killer (NK) Cell Therapeutics Market Volume (‘000 tones) & Y-o-Y Growth (%) Analysis, 2023–2030
Figure 03: Natural Killer (NK) Cell Therapeutics, Pricing Analysis per unit (US$), in 2022
Figure 04: Natural Killer (NK) Cell Therapeutics, Pricing Forecast per unit (US$), in 2028
Figure 05: Global Natural Killer (NK) Cell Therapeutics Market Value Analysis (US$ Mn), 2019-2022
Figure 06: Global Natural Killer (NK) Cell Therapeutics Market Size (US$ Mn) & Y-o-Y Growth (%) Analysis, 2023–2030
Figure 07: Global Natural Killer (NK) Cell Therapeutics Market Size and Market Share Analysis (%) by Application, 2023 & 2030
Figure 08: Global Natural Killer (NK) Cell Therapeutics Market Y-o-Y Analysis (%) by Application, 2019-2028
Figure 09: Global Natural Killer (NK) Cell Therapeutics Market Size and Market Share Analysis (%) by End User, 2023 & 2030
Figure 10: Global Natural Killer (NK) Cell Therapeutics Market Y-o-Y Analysis (%) by End User, 2019-2028
Figure 11: Global Natural Killer (NK) Cell Therapeutics Market Size and Market Share Analysis (%) by Region, 2023 & 2030
Figure 12: Global Natural Killer (NK) Cell Therapeutics Market Y-o-Y Growth (%) by Region, 2023–2030
Figure 13: North America Natural Killer (NK) Cell Therapeutics Market Size and Market Share Analysis (%) by Application, 2023 & 2030
Figure 14: North America Natural Killer (NK) Cell Therapeutics Market Size and Market Share Analysis (%) by End User, 2023 & 2030
Figure 15: North America Natural Killer (NK) Cell Therapeutics Market Size and Market Share Analysis (%) by Country, 2023 & 2030
Figure 16: Latin America Natural Killer (NK) Cell Therapeutics Market Size and Market Share Analysis (%) by Application, 2023 & 2030
Figure 17: Latin America Natural Killer (NK) Cell Therapeutics Market Size and Market Share Analysis (%) by End User, 2023 & 2030
Figure 18: Latin America Natural Killer (NK) Cell Therapeutics Market Size and Market Share Analysis (%) by Country, 2023 & 2030
Figure 19: Western Europe Natural Killer (NK) Cell Therapeutics Market Size and Market Share Analysis (%) by Application, 2023 & 2030
Figure 20: Western Europe Natural Killer (NK) Cell Therapeutics Market Size and Market Share Analysis (%) by End User, 2023 & 2030
Figure 21: Western Europe Natural Killer (NK) Cell Therapeutics Market Size and Market Share Analysis (%) by Country, 2023 & 2030
Figure 22: Eastern Europe Natural Killer (NK) Cell Therapeutics Market Size and Market Share Analysis (%) by Application, 2023 & 2030
Figure 23: Eastern Europe Natural Killer (NK) Cell Therapeutics Market Size and Market Share Analysis (%) by End User, 2023 & 2030
Figure 24: Eastern Europe Natural Killer (NK) Cell Therapeutics Market Size and Market Share Analysis (%) by Country, 2023 & 2030
Figure 25: Asia Pacific Natural Killer (NK) Cell Therapeutics Market Size and Market Share Analysis (%) by Application, 2023 & 2030
Figure 26: Asia Pacific Natural Killer (NK) Cell Therapeutics Market Size and Market Share Analysis (%) by End User, 2023 & 2030
Figure 27: Asia Pacific Natural Killer (NK) Cell Therapeutics Market Size and Market Share Analysis (%) by Country, 2023 & 2030
Figure 28: Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size and Market Share Analysis (%) by Application, 2023 & 2030
Figure 29: Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size and Market Share Analysis (%) by End User, 2023 & 2030
Figure 30: Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size and Market Share Analysis (%) by Country, 2023 & 2030
List of Tables
Table 1: Global Natural Killer (NK) Cell Therapeutics Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Application
Table 2: Global Natural Killer (NK) Cell Therapeutics Market Volume (‘000 tones) Analysis and Forecast 2019-2028, by Application
Table 3: Global Natural Killer (NK) Cell Therapeutics Market Value (US$ Mn) Analysis and Forecast 2019-2028, by End User
Table 4: Global Natural Killer (NK) Cell Therapeutics Market Volume (‘000 tones) Analysis and Forecast 2019-2028, by End User
Table 5: Global Natural Killer (NK) Cell Therapeutics Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Region
Table 6: Global Natural Killer (NK) Cell Therapeutics Market Volume (‘000 tones) Analysis and Forecast 2019-2028, by Region
Table 7: North America Natural Killer (NK) Cell Therapeutics Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Application
Table 8: North America Natural Killer (NK) Cell Therapeutics Market Volume (‘000 tones) Analysis and Forecast 2019-2028, by Application
Table 9: North America Natural Killer (NK) Cell Therapeutics Market Value (US$ Mn) Analysis and Forecast 2019-2028, by End User
Table 10: North America Natural Killer (NK) Cell Therapeutics Market Volume (‘000 tones) Analysis and Forecast 2019-2028, by End User
Table 11: North America Natural Killer (NK) Cell Therapeutics Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Country
Table 12: North America Natural Killer (NK) Cell Therapeutics Market Volume (‘000 tones) Analysis and Forecast 2019-2028, by Country
Table 13: Latin America Natural Killer (NK) Cell Therapeutics Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Application
Table 14: Latin America Natural Killer (NK) Cell Therapeutics Market Volume (‘000 tones) Analysis and Forecast 2019-2028, by Application
Table 15: Latin America Natural Killer (NK) Cell Therapeutics Market Value (US$ Mn) Analysis and Forecast 2019-2028, by End User
Table 16: Latin America Natural Killer (NK) Cell Therapeutics Market Volume (‘000 tones) Analysis and Forecast 2019-2028, by End User
Table 17: Latin America Natural Killer (NK) Cell Therapeutics Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Country
Table 18: Latin America Natural Killer (NK) Cell Therapeutics Market Volume (‘000 tones) Analysis and Forecast 2019-2028, by Country
Table 19: Western Europe Natural Killer (NK) Cell Therapeutics Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Application
Table 20: Western Europe Natural Killer (NK) Cell Therapeutics Market Volume (‘000 tones) Analysis and Forecast 2019-2028, by Application
Table 21: Western Europe Natural Killer (NK) Cell Therapeutics Market Value (US$ Mn) Analysis and Forecast 2019-2028, by End User
Table 22: Western Europe Natural Killer (NK) Cell Therapeutics Market Volume (‘000 tones) Analysis and Forecast 2019-2028, by End User
Table 23: Western Europe Natural Killer (NK) Cell Therapeutics Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Country
Table 24: Western Europe Natural Killer (NK) Cell Therapeutics Market Volume (‘000 tones) Analysis and Forecast 2019-2028, by Country
Table 25: Eastern Europe Natural Killer (NK) Cell Therapeutics Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Application
Table 26: Eastern Europe Natural Killer (NK) Cell Therapeutics Market Volume (‘000 tones) Analysis and Forecast 2019-2028, by Application
Table 27: Eastern Europe Natural Killer (NK) Cell Therapeutics Market Value (US$ Mn) Analysis and Forecast 2019-2028, by End User
Table 28: Eastern Europe Natural Killer (NK) Cell Therapeutics Market Volume (‘000 tones) Analysis and Forecast 2019-2028, by End User
Table 29: Eastern Europe Natural Killer (NK) Cell Therapeutics Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Country
Table 30: Eastern Europe Natural Killer (NK) Cell Therapeutics Market Volume (‘000 tones) Analysis and Forecast 2019-2028, by Country
Table 31: Asia Pacific Natural Killer (NK) Cell Therapeutics Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Application
Table 32: Asia Pacific Natural Killer (NK) Cell Therapeutics Market Volume (‘000 tones) Analysis and Forecast 2019-2028, by Application
Table 33: Asia Pacific Natural Killer (NK) Cell Therapeutics Market Value (US$ Mn) Analysis and Forecast 2019-2028, by End User
Table 34: Asia Pacific Natural Killer (NK) Cell Therapeutics Market Volume (‘000 tones) Analysis and Forecast 2019-2028, by End User
Table 35: Asia Pacific Natural Killer (NK) Cell Therapeutics Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Country
Table 36: Asia Pacific Natural Killer (NK) Cell Therapeutics Market Volume (‘000 tones) Analysis and Forecast 2019-2028, by Country
Table 37: Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Application
Table 38: Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Volume (‘000 tones) Analysis and Forecast 2019-2028, by Application
Table 39: Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Value (US$ Mn) Analysis and Forecast 2019-2028, by End User
Table 40: Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Volume (‘000 tones) Analysis and Forecast 2019-2028, by End User
Table 41: Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Country
Table 42: Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Volume (‘000 tones) Analysis and Forecast 2019-2028, by Country
List of Figures
Research methodology is mainly referring to the practical how of any offered piece of research. More specifically, it’s all about how a researcher systematically designs a study in order to assure extremely valid as well as reliable results that ultimately address the targets and objectives of the research.
In any formal research including academic journal, article, dissertation and so on, there will be a special section on a research methodology that mainly describes what, by whom, how to gather as well as how to evaluate the data are provided.
This research methodology has been segmented into following types:
Primary Research:
It is said to be original information that the researchers collect for the crucial purposes of answering the research questions of readers with the help of surveys, observations and experiments.
Secondary Research:
The secondary research is the data that has already been collected by various other researchers in the form of government analysis or scientific studies.
Qualitative Research:
It is descriptive and subjective method irrespective of facts. Both observation and description are essential in this type of research methodology. Its main vision is to analyze knowledge, attitudes, behaviours as well as opinions of people related to the topic of any research. This method has been operated through grounded research, case study and actionable research.
Quantitative Research:
It contains several laboratory experiments, basic surveys, mathematical calculations, simulations and so on. The possible measurement, quantity or amount is considered to be a major factor in the quantitative research methodology.
Clients
